| Active ingredient |
|
Pharmaceutical form |
| Anastrozol |
∙ |
Tablets 1 mg |
| Bortezomib |
∙ |
Powder for solution for injection 3.5 mg |
| Carboplatin |
∙ |
Solution for infusion 10 mg/ml |
| Docetaxel |
∙ |
Concentrate for solution for infusion 40 mg/ml, 2.0 ml (80mg) in vials №1 with solvent 7.1 ml in vials №1 |
| Epirubicin |
∙ |
Solution for injection 2 mg/ml |
| Erlotinib |
∙ |
Tablets 150 mg |
| Fludarabine |
∙ |
Lyophilizate for solution for injections 50 mg |
| Gemcitabine |
∙ |
Lyophilizate for solution for infusion 200 mg, 1000 mg |
| Imatinib |
∙ |
Tablets 100 mg |
| Imatinib |
∙ |
Capsules 400 mg |
| Irinotecan |
∙ |
Concentrate for solution for infusion 20 mg/ml |
| Ondansetron |
∙ |
Solution for injection 4 mg/2 ml, 8 mg/4 ml |
| Oxaliplatin |
∙ |
Concentrate for solution for infusion 5 mg/ml |
| Methotrexate |
∙ |
Solution for infusion 50 mg/ 2 ml |
| Temozolomide |
∙ |
Capsules 20 mg, 100 mg, 250 mg |
| Palonosetron |
∙ |
Solution for injection 50 mcg/ml |
| Paclitaxel |
∙ |
Concentrate for solution for infusion 6 mg/ml |
| Pemetrexed Sodium |
∙ |
Solution for infusion 100 mg, 500 mg |
| 5-Fluorouracil |
∙ |
Solution for infusion 250 mg/ 5 ml, 500 mg/ 10 ml, 1000 mg/ 20 ml, 5000 mg/ 100 ml |
